Literature DB >> 18023615

Meeting the ongoing needs of survivors of rarer cancer.

Jane Griffiths1, Carole Willard, Andrea Burgess, Ziv Amir, Karen Luker.   

Abstract

With more treatment options for people with cancer long-term survivorship is increasing. Physical and psycho-social needs have been identified in survivors of common cancers but very little has been written about the needs of patients with rarer cancers. Patients treated for rarer cancer are discharged to the primary health care team (PHCT), yet little is known about the assessment, management and support of these patients. Thirty-nine semi-structured interviews were conducted with (1) survivors of and (2) people living with rarer cancer (i.e. <5% of cancer burden). Participants were asked about physical and psycho-social needs and service provision. Data were analysed thematically using Atlas ti. Contrary to expectation, disease-free survivors of rarer cancer were indistinguishable from those living with disease in their ability to cope, and range of symptoms and needs. Participants with a clinical nurse specialist (CNS) reported that they were well supported on their return home and their needs were met. Participants without a CNS were referred to the PHCT who were unsure how to assess or support them. These participants felt abandoned. There is a need for the rehabilitation of patients with rarer cancer to strengthen individual coping mechanisms, and family and social support. Although there are resource and training implications, this is a potential role for the PHCT, district nursing in particular, and may lead to more focused and targeted provision of services.

Entities:  

Mesh:

Year:  2007        PMID: 18023615     DOI: 10.1016/j.ejon.2007.09.004

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  8 in total

1.  The importance of symptom surveillance during follow-up care of leukemia, bladder, and colorectal cancer survivors.

Authors:  Erin E Kent; Sandra A Mitchell; Ingrid Oakley-Girvan; Neeraj K Arora
Journal:  Support Care Cancer       Date:  2013-09-10       Impact factor: 3.603

Review 2.  Involvement of patients with lung and gynecological cancer and their relatives in psychosocial cancer rehabilitation: a narrative review.

Authors:  Bente Hoeck; Loni Ledderer; Helle Ploug Hansen
Journal:  Patient       Date:  2015-04       Impact factor: 3.883

3.  The End-of-Life Experience of Patients With Rare Cancers and Their Caregivers.

Authors:  Elizabeth Trice Loggers; Holly G Prigerson
Journal:  Rare Tumors       Date:  2014-03-24

4.  Living with idiopathic basal ganglia calcification 3: a qualitative study describing the lives and illness of people diagnosed with a rare neurological disease.

Authors:  Tomiko Takeuchi; Koko Muraoka; Megumi Yamada; Yuri Nishio; Isao Hozumi
Journal:  Springerplus       Date:  2016-10-04

5.  Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs.

Authors:  Simron Singh; Dan Granberg; Edward Wolin; Richard Warner; Maia Sissons; Teodora Kolarova; Grace Goldstein; Marianne Pavel; Kjell Öberg; John Leyden
Journal:  J Glob Oncol       Date:  2016-06-08

6.  Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States.

Authors:  Edward M Wolin; John Leyden; Grace Goldstein; Teodora Kolarova; Ron Hollander; Richard R P Warner
Journal:  Pancreas       Date:  2017 May/Jun       Impact factor: 3.327

7.  Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers.

Authors:  Alannah Smrke; Eugenie Younger; Roger Wilson; Olga Husson; Sheima Farag; Eve Merry; Aislinn Macklin-Doherty; Elena Cojocaru; Amani Arthur; Charlotte Benson; Aisha B Miah; Shane Zaidi; Spyridon Gennatas; Robin L Jones
Journal:  JCO Glob Oncol       Date:  2020-07

8.  Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey.

Authors:  Eline de Heus; Vivian Engelen; Irene Dingemans; Carol Richel; Marga Schrieks; Jan Maarten van der Zwan; Marc G Besselink; Mark I van Berge Henegouwen; Carla M L van Herpen; Saskia F A Duijts
Journal:  Orphanet J Rare Dis       Date:  2021-06-01       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.